Verity Asset Management Inc. Has $1.99 Million Stake in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Verity Asset Management Inc. lifted its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 0.9% during the third quarter, Holdings Channel reports. The fund owned 20,089 shares of the exchange traded fund’s stock after buying an additional 179 shares during the quarter. Verity Asset Management Inc.’s holdings in SPDR S&P Biotech ETF were worth $1,985,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of XBI. Advisor Resource Council bought a new stake in SPDR S&P Biotech ETF in the 3rd quarter valued at about $260,000. Graypoint LLC increased its holdings in shares of SPDR S&P Biotech ETF by 5.6% during the third quarter. Graypoint LLC now owns 2,738 shares of the exchange traded fund’s stock valued at $271,000 after acquiring an additional 146 shares in the last quarter. Quintet Private Bank Europe S.A. acquired a new position in shares of SPDR S&P Biotech ETF during the third quarter worth approximately $40,000. GFS Advisors LLC lifted its holdings in shares of SPDR S&P Biotech ETF by 1,314.7% in the 3rd quarter. GFS Advisors LLC now owns 18,957 shares of the exchange traded fund’s stock worth $1,873,000 after purchasing an additional 17,617 shares in the last quarter. Finally, Conservest Capital Advisors Inc. grew its position in SPDR S&P Biotech ETF by 23.5% in the 3rd quarter. Conservest Capital Advisors Inc. now owns 40,813 shares of the exchange traded fund’s stock valued at $3,873,000 after purchasing an additional 7,772 shares during the period.

SPDR S&P Biotech ETF Trading Up 0.5 %

Shares of XBI stock opened at $102.99 on Friday. SPDR S&P Biotech ETF has a 12 month low of $64.99 and a 12 month high of $103.89. The firm has a market capitalization of $7.85 billion, a PE ratio of 11.47 and a beta of 1.11. The firm has a fifty day simple moving average of $98.90 and a two-hundred day simple moving average of $95.38.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.